Close

Mizuho Securities Downgrades Amedisys (AMED) to Neutral

July 26, 2017 5:05 AM EDT Send to a Friend
Mizuho Securities downgraded Amedisys (NASDAQ: AMED) from Buy to Neutral with a price target of $50.00.Analyst Dr. Sheryl Skolnic has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login